Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$12,011,152
-$25,907 QoQ
Shares Held
93,472
-6.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#681
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. MRK ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,011,152 | 93,472 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $12,037,059 | 100,067 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $10,605,470 | 100,755 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $8,542,730 | 101,784 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $8,045,980 | 101,642 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $9,205,156 | 102,553 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $9,959,937 | 100,120 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $11,193,267 | 98,567 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $12,085,479 | 97,621 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $13,103,953 | 99,310 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $10,807,914 | 99,137 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $9,298,237 | 90,318 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $9,373,706 | 81,235 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $9,032,404 | 84,899 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $9,518,399 | 85,790 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $7,585,363 | 88,079 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $8,025,330 | 88,026 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $7,274,552 | 88,660 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $6,238,342 | 81,398 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $6,069,488 | 80,808 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $6,127,115 | 79,480 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $6,326,653 | 77,343 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,005,167 | 72,395 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $5,521,982 | 71,408 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $5,144,205 | 66,860 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||